These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34796738)

  • 1. Risk Classification for Metabolic Syndrome and the Incidence of Cardiovascular Disease in Japan With Low Prevalence of Obesity: A Pooled Analysis of 10 Prospective Cohort Studies.
    Iso H; Cui R; Takamoto I; Kiyama M; Saito I; Okamura T; Miyamoto Y; Higashiyama A; Kiyohara Y; Ninomiya T; Yamada M; Nakagawa H; Sakurai M; Shimabukuro M; Higa M; Shimamoto K; Saito S; Daimon M; Kayama T; Noda M; Ito S; Yokote K; Ito C; Nakao K; Yamauchi T; Kadowaki T
    J Am Heart Assoc; 2021 Dec; 10(23):e020760. PubMed ID: 34796738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population attributable fraction of smoking and metabolic syndrome on cardiovascular disease mortality in Japan: a 15-year follow up of NIPPON DATA90.
    Takashima N; Miura K; Hozawa A; Kadota A; Okamura T; Nakamura Y; Hayakawa T; Okuda N; Fujiyoshi A; Nagasawa SY; Kadowaki T; Murakami Y; Kita Y; Okayama A; Ueshima H;
    BMC Public Health; 2010 Jun; 10():306. PubMed ID: 20525280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-Risk Human Papillomavirus Infection and the Risk of Cardiovascular Disease in Korean Women.
    Joo EJ; Chang Y; Kwon MJ; Cho A; Cheong HS; Ryu S
    Circ Res; 2019 Mar; 124(5):747-756. PubMed ID: 30727837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of Cardiovascular Disease in Individuals With Nonobese Nonalcoholic Fatty Liver Disease.
    Arvind A; Henson JB; Osganian SA; Nath C; Steinhagen LM; Memel ZN; Donovan A; Balogun O; Chung RT; Simon TG; Corey KE
    Hepatol Commun; 2022 Feb; 6(2):309-319. PubMed ID: 34558862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk and population attributable fraction of metabolic syndrome and impaired fasting glucose for the incidence of type 2 diabetes mellitus among middle-aged Japanese individuals: Aichi Worker's Cohort Study.
    Kaneko K; Yatsuya H; Li Y; Uemura M; Chiang C; Hirakawa Y; Ota A; Tamakoshi K; Aoyama A
    J Diabetes Investig; 2020 Sep; 11(5):1163-1169. PubMed ID: 32022993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolically Healthy Obesity and the Risk of Cardiovascular Disease in the Elderly Population.
    Dhana K; Koolhaas CM; van Rossum EF; Ikram MA; Hofman A; Kavousi M; Franco OH
    PLoS One; 2016; 11(4):e0154273. PubMed ID: 27100779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Major Cardiovascular Risk Factors on the Incidence of Cardiovascular Disease among Overweight and Non-Overweight Individuals: The Circulatory Risk in Communities Study (CIRCS).
    Matsumura T; Sankai T; Yamagishi K; Kubota Y; Hayama-Terada M; Muraki I; Umesawa M; Cui R; Imano H; Ohira T; Kitamura A; Okada T; Kiyama M; Iso H
    J Atheroscler Thromb; 2022 Mar; 29(3):422-437. PubMed ID: 33731540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spousal metabolic risk factors and future cardiovascular events: A prospective cohort study.
    Ramezankhani A; Guity K; Azizi F; Hadaegh F
    Atherosclerosis; 2020 Apr; 298():36-41. PubMed ID: 32169721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between metabolic syndrome and mortality from cardiovascular disease in Japanese general population, findings on overweight and non-overweight individuals. Ibaraki Prefectural Health Study.
    Irie F; Iso H; Noda H; Sairenchi T; Otaka E; Yamagishi K; Doi M; Izumi Y; Ota H
    Circ J; 2009 Sep; 73(9):1635-42. PubMed ID: 19590142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome and all-cause and cardiovascular disease mortality: Japan Public Health Center-based Prospective (JPHC) Study.
    Saito I; Iso H; Kokubo Y; Inoue M; Tsugane S
    Circ J; 2009 May; 73(5):878-84. PubMed ID: 19282609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body mass index and waist circumference predict both 10-year nonfatal and fatal cardiovascular disease risk: study conducted in 20,000 Dutch men and women aged 20-65 years.
    van Dis I; Kromhout D; Geleijnse JM; Boer JM; Verschuren WM
    Eur J Cardiovasc Prev Rehabil; 2009 Dec; 16(6):729-34. PubMed ID: 19809330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low testosterone concentrations in men contribute to the gender gap in cardiovascular morbidity and mortality.
    Haring R; John U; Völzke H; Nauck M; Dörr M; Felix SB; Wallaschofski H
    Gend Med; 2012 Dec; 9(6):557-68. PubMed ID: 23182129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying cardiovascular disease risk and outcome: use of the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio versus metabolic syndrome criteria.
    Salazar MR; Carbajal HA; Espeche WG; Aizpurúa M; Leiva Sisnieguez CE; March CE; Balbín E; Stavile RN; Reaven GM
    J Intern Med; 2013 Jun; 273(6):595-601. PubMed ID: 23331522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between metabolic risk factor clustering and cardiovascular mortality stratified by high blood glucose and obesity: NIPPON DATA90, 1990-2000.
    Kadota A; Hozawa A; Okamura T; Kadowak T; Nakmaura K; Murakami Y; Hayakawa T; Kita Y; Okayama A; Nakamura Y; Kashiwagi A; Ueshima H;
    Diabetes Care; 2007 Jun; 30(6):1533-8. PubMed ID: 17363755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity in young South African women living with HIV: A cross-sectional analysis of risk factors for cardiovascular disease.
    Hanley S; Moodley D; Naidoo M
    PLoS One; 2021; 16(11):e0255652. PubMed ID: 34780476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between transition from metabolically healthy obesity to metabolic syndrome, and incidence of cardiovascular disease: Tehran lipid and glucose study.
    Hosseinpanah F; Tasdighi E; Barzin M; Mahdavi M; Ghanbarian A; Valizadeh M; Azizi F
    PLoS One; 2020; 15(9):e0239164. PubMed ID: 32947607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender-related differences in the prevalence of cardiovascular disease risk factors and their correlates in urban Tanzania.
    Njelekela MA; Mpembeni R; Muhihi A; Mligiliche NL; Spiegelman D; Hertzmark E; Liu E; Finkelstein JL; Fawzi WW; Willett WC; Mtabaji J
    BMC Cardiovasc Disord; 2009 Jul; 9():30. PubMed ID: 19615066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex-specific clustering of metabolic risk factors and their association with incident cardiovascular diseases: A population-based prospective study.
    Ramezankhani A; Azizi F; Hadaegh F; Eskandari F
    Atherosclerosis; 2017 Aug; 263():249-256. PubMed ID: 28683364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct component profiles and high risk among African Americans with metabolic syndrome: the Jackson Heart Study.
    Taylor H; Liu J; Wilson G; Golden SH; Crook E; Brunson CD; Steffes M; Johnson WD; Sung JH
    Diabetes Care; 2008 Jun; 31(6):1248-53. PubMed ID: 18332154
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.